GREM1 and pulmonary arterial hypertension: Interestingly, in contrast to the antibodies against Activin A and TGF-β, anti-Gremlin 1 antibody, while dramatically increasing phosphorylation of all tested Smads and reducing ERK1/2 phosphorylation, did not affect human PAH PAVSMC growth and proliferation.